Corey M. Munger

发表

Cytotoxicity of Cord Blood Derived Her2/neu-specific Cytotoxic T Lymphocytes against Human Breast Cancer in vitro and in vivo

S. Joshi, S. Pirruccello, A. Joshi, 2004, Breast Cancer Research and Treatment.

Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma

D. Weisenburger, J. Vose, S. Joshi, 2012, Cancer Immunology, Immunotherapy.

Immunotherapy of Human Neuroblastoma Using Umbilical Cord Blood-Derived Effector Cells

S. Joshi, G. Hegde, S. Sanderson, 2007, Journal of Neuroimmune Pharmacology.

Novel therapy for therapy‐resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling

D. Weisenburger, P. Bierman, J. Vose, 2012, International journal of cancer.

Dendritic Cell-based Therapy for Mantle Cell Lymphoma

D. Weisenburger, J. Vose, S. Joshi, 2007 .

Dendritic cell-based therapy for mantle cell lymphoma.

J. Vose, S. Joshi, Corey M. Munger, 2006, International journal of oncology.

Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity.

J. Talmadge, J. Chavez, K. Yates, 2004, International immunopharmacology.

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

T. Greiner, D. Weisenburger, J. Vose, 2008, Molecular Cancer Therapeutics.

Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses

J. Talmadge, Ya-jun Guo, Rakesh K. Singh, 2005, Cancer Gene Therapy.

Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.

J. Talmadge, Ya-jun Guo, P. Parajuli, 2003, Vaccine.